150 related articles for article (PubMed ID: 38056310)
1. ALS-linked SOD1 mutations impair mitochondrial-derived vesicle formation and accelerate aging.
Guo Y; Guan T; Yu Q; Sanghai N; Shafiq K; Li M; Jiao X; Na D; Zhang G; Kong J
Redox Biol; 2024 Feb; 69():102972. PubMed ID: 38056310
[TBL] [Abstract][Full Text] [Related]
2. Oxidized SOD1 accelerates cellular senescence in neural stem cells.
Guan T; Guo Y; Zhou T; Yu Q; Sun J; Sun B; Zhang G; Kong J
Stem Cell Res Ther; 2024 Feb; 15(1):55. PubMed ID: 38414053
[TBL] [Abstract][Full Text] [Related]
3. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
4. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.
Gertz B; Wong M; Martin LJ
J Neuropathol Exp Neurol; 2012 Feb; 71(2):162-77. PubMed ID: 22249462
[TBL] [Abstract][Full Text] [Related]
5. Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosis.
Guan T; Zhou T; Zhang X; Guo Y; Yang C; Lin J; Zhang JV; Cheng Y; Marzban H; Wang YT; Kong J
Cell Mol Life Sci; 2023 Sep; 80(10):304. PubMed ID: 37752364
[TBL] [Abstract][Full Text] [Related]
6. ALS-associated mutation SOD1
Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J
Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231
[TBL] [Abstract][Full Text] [Related]
7. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis.
Turner BJ; Atkin JD; Farg MA; Zang DW; Rembach A; Lopes EC; Patch JD; Hill AF; Cheema SS
J Neurosci; 2005 Jan; 25(1):108-17. PubMed ID: 15634772
[TBL] [Abstract][Full Text] [Related]
8. Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model.
Vargas MR; Johnson DA; Johnson JA
Neurobiol Dis; 2011 Sep; 43(3):543-51. PubMed ID: 21600285
[TBL] [Abstract][Full Text] [Related]
9. MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1
Peng J; Pan J; Mo J; Peng Y
Oxid Med Cell Longev; 2022; 2022():8217663. PubMed ID: 35178161
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1.
Brasil AA; de Carvalho MDC; Gerhardt E; Queiroz DD; Pereira MD; Outeiro TF; Eleutherio ECA
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25991-26000. PubMed ID: 31796595
[TBL] [Abstract][Full Text] [Related]
11. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
12. OPTN gene therapy increases autophagy and protects mitochondria in SOD1-G93A-expressing transgenic mice and cells.
Wen D; Ji Y; Li Y; Duan W; Wang Y; Li Z; Tao M; Liu Y
FEBS J; 2024 Feb; 291(4):795-813. PubMed ID: 37983563
[TBL] [Abstract][Full Text] [Related]
13. NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1
Yang B; Pan J; Zhang XN; Wang H; He L; Rong X; Li X; Peng Y
Neurobiol Dis; 2023 Aug; 184():106210. PubMed ID: 37352984
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide Riboside Enhances Mitochondrial Proteostasis and Adult Neurogenesis through Activation of Mitochondrial Unfolded Protein Response Signaling in the Brain of ALS SOD1
Zhou Q; Zhu L; Qiu W; Liu Y; Yang F; Chen W; Xu R
Int J Biol Sci; 2020; 16(2):284-297. PubMed ID: 31929756
[TBL] [Abstract][Full Text] [Related]
15. Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis.
Huo D; Liang W; Wang D; Liu Q; Wang H; Wang Y; Zhang C; Cong C; Su X; Tan X; Zhang W; Han L; Zhang D; Wang M; Feng H
Neuropharmacology; 2024 Apr; 247():109812. PubMed ID: 38218579
[TBL] [Abstract][Full Text] [Related]
16. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS).
Lee NY; Kim Y; Ryu H; Kang YS
Biochem Biophys Res Commun; 2017 Jan; 483(1):135-141. PubMed ID: 28043791
[TBL] [Abstract][Full Text] [Related]
17. Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice.
Xu G; Ayers JI; Roberts BL; Brown H; Fromholt S; Green C; Borchelt DR
Hum Mol Genet; 2015 Feb; 24(4):1019-35. PubMed ID: 25305079
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.
Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR
PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis.
Cimini S; Rizzardini M; Biella G; Cantoni L
J Neurochem; 2014 May; 129(3):413-25. PubMed ID: 24359187
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.
Moller A; Bauer CS; Cohen RN; Webster CP; De Vos KJ
Hum Mol Genet; 2017 Dec; 26(23):4668-4679. PubMed ID: 28973175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
